stella
beta
Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer — Stella
Recruiting
Back to Head and Neck Carcinoma of Unknown Primary trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Ohio State University Comprehensive Cancer Center, Columbus, Ohio
View full record on ClinicalTrials.gov